538 related articles for article (PubMed ID: 26483322)
21. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR
Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243
[TBL] [Abstract][Full Text] [Related]
22. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
23. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.
Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M
Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438
[TBL] [Abstract][Full Text] [Related]
24. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
Zhang BF; Song W; Wang J; Wen PF; Zhang YM
J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
[TBL] [Abstract][Full Text] [Related]
25. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury.
Mi L; Zhang Y; Xu Y; Zheng X; Zhang X; Wang Z; Xue M; Jin X
Biomed Pharmacother; 2019 Aug; 116():109005. PubMed ID: 31136947
[TBL] [Abstract][Full Text] [Related]
26. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
[TBL] [Abstract][Full Text] [Related]
27. The role of Toll-like receptor 4 in apoptosis of brain tissue after induction of intracerebral hemorrhage.
Fei X; He Y; Chen J; Man W; Chen C; Sun K; Ding B; Wang C; Xu R
J Neuroinflammation; 2019 Nov; 16(1):234. PubMed ID: 31771613
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of post-hemorrhagic shock mesenteric lymph drainage on the HMGB1 and RAGE in mouse kidney.
Liu GQ; Zuo XH; Jiang LN; Zhang YP; Zhang LM; Zhao ZG; Niu CY
Ren Fail; 2016; 38(1):131-6. PubMed ID: 26513053
[TBL] [Abstract][Full Text] [Related]
29. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
[TBL] [Abstract][Full Text] [Related]
30. Ginkgolide B reduces neuronal cell apoptosis in the hemorrhagic rat brain: possible involvement of Toll-like receptor 4/nuclear factor-kappa B pathway.
Hu YY; Huang M; Dong XQ; Xu QP; Yu WH; Zhang ZY
J Ethnopharmacol; 2011 Oct; 137(3):1462-8. PubMed ID: 21878382
[TBL] [Abstract][Full Text] [Related]
31. High-mobility group Box-1 is involved in NMDA-induced retinal injury the in rat retina.
Sakamoto K; Mizuta A; Fujimura K; Kurauchi Y; Mori A; Nakahara T; Ishii K
Exp Eye Res; 2015 Aug; 137():63-70. PubMed ID: 26079740
[TBL] [Abstract][Full Text] [Related]
32. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
Herzog C; Lorenz A; Gillmann HJ; Chowdhury A; Larmann J; Harendza T; Echtermeyer F; Müller M; Schmitz M; Stypmann J; Seidler DG; Damm M; Stehr SN; Koch T; Wollert KC; Conway EM; Theilmeier G
Cardiovasc Res; 2014 Mar; 101(3):400-10. PubMed ID: 24323314
[TBL] [Abstract][Full Text] [Related]
33. Brain recovery mediated by toll-like receptor 4 in rats after intracerebral hemorrhage.
Lei C; Wu B; Cao T; Liu M; Hao Z
Brain Res; 2016 Feb; 1632():1-8. PubMed ID: 26657742
[TBL] [Abstract][Full Text] [Related]
34. TLR2-induced astrocyte MMP9 activation compromises the blood brain barrier and exacerbates intracerebral hemorrhage in animal models.
Min H; Hong J; Cho IH; Jang YH; Lee H; Kim D; Yu SW; Lee S; Lee SJ
Mol Brain; 2015 Apr; 8():23. PubMed ID: 25879213
[TBL] [Abstract][Full Text] [Related]
35. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.
Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H
Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451
[TBL] [Abstract][Full Text] [Related]
36. Role of high mobility group box 1 (HMGB1) in wound healing.
Zhang Q; O'Hearn S; Kavalukas SL; Barbul A
J Surg Res; 2012 Jul; 176(1):343-7. PubMed ID: 21872885
[TBL] [Abstract][Full Text] [Related]
37. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.
Wang J; Wang H; Shi J; Ding Y
Int J Clin Exp Pathol; 2015; 8(10):12028-40. PubMed ID: 26722388
[TBL] [Abstract][Full Text] [Related]
38. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
[TBL] [Abstract][Full Text] [Related]
39. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.
Ahrens I; Chen YC; Topcic D; Bode M; Haenel D; Hagemeyer CE; Seeba H; Duerschmied D; Bassler N; Jandeleit-Dahm KA; Sweet MJ; Agrotis A; Bobik A; Peter K
Thromb Haemost; 2015 Nov; 114(5):994-1003. PubMed ID: 26202300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
